Parexel to be acquired in $8.5bn private-equity deal

Parexel to be acquired in $8.5bn private-equity deal

Parexel has executed a definitive merger agreement, and will be acquired for $8.5 billion, the company announced today. Parexel, recently named “Best Contract Research Organization” by an independent panel for Informa Pharma Intelligence, will be acquired by EQT IX...